// App-Quantinova.ai

: Fms-like Tyrosine Kinase 3 Ligand Concentration Kinetic Profile during Induction Is Strongly Predictive of Survivals in AML: Results of the FLAM/Flal Study

Researchers

Presenter

  • Pierre Peterlin

Principal Investigators

  • Thierry Guillaume

  • Alice Garnier

  • Marion Eveillard

  • Amandine Le Bourgeois

  • Michel Cherel

  • Camille Debord

  • Yannick LE Bris

  • Olivier Theisen

  • Beatrice Mahe

  • Viviane Dubruille

  • Soraya Wuilleme

  • Catherine Godon

  • Cyrille Touzeau

  • Thomas Gastinne

  • Nicolas Blin

  • Anne Lok

  • Antoine Bonnet

  • Steven LE Gouill

  • Philippe Moreau

  • Marie C Bene

  • Patrice Chevallier

Medical Centers

  • Pediatric Hematology, Nantes University Hospital, Nantes, France

  • CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France

  • Nuclear Medicine Unit, ICO Cancer Center Gauducheau, Saint Herblain, France

  • Hematology Clinic, CHU Nantes, Nantes, France

  • Hematology, University Hospital, Nantes, France

  • University Hospital Hotel-Dieu, Nantes, France

  • CRCINA, INSERM, CNRS, Angers University and Nantes University, Nantes, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • White Blood Cell

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • I

Study Id's

  • NCT02693899

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved